Mitolactol

Drug Profile

Mitolactol

Alternative Names: Bromoalcohol; DBD; Dibromodulcitol; Elobromol; Metholactole; Mitolactol-Chinoin; NSC 104800; WR 138743

Latest Information Update: 07 Aug 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Chinoin
  • Class Antineoplastics; Peptides
  • Mechanism of Action Alkylating agents; DNA inhibitors; DNA synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Market Withdrawal Cancer
  • Discontinued Brain cancer; Cervical cancer

Most Recent Events

  • 07 Aug 2006 Discontinued - Phase-III for Brain cancer in USA (PO)
  • 11 Dec 2003 Mitolactol has been licensed to Targent
  • 11 Dec 2003 Phase-III clinical trials in Brain cancer in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top